Stanley Stein
18Patents
6h-index
27Co-inventors
66Inventor score
Filing activity: Aug 5, 1977 → Mar 12, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4116046A | Liquid chromatography system | Physics | 44 | Expired |
| USD371491S | Baby food storing and dispensing spoon | General | 15 | Expired |
| US6258774A | Carrier for in vivo delivery of a therapeutic agent | Human Necessities | 13 | Expired |
| US6617306B2 | Carrier for in vivo delivery of a therapeutic agent | Human Necessities | 13 | Expired |
| US7846893B2 | Drug-polymer conjugates coupled to a peptidic carrier | Human Necessities | 7 | Active |
| US9211358B2 | Dressing compositions and methods | Human Necessities | 6 | Active |
| US6468522B1 | Controlled release of thioamide moiety-containing therapeutic agents | Emerging Cross-Sectional Technologies | 6 | Expired |
| US4388236A | Enkephalin-like compounds in bovine adrenal medulla | Emerging Cross-Sectional Technologies | 5 | Expired |
| US4264492A | Enkephalin-like compounds in bovine adrenal medulla | Human Necessities | 4 | Expired |
| US6210655A | Site-specific 13C-enriched reagents for diagnostic medicine by magnetic resonance imaging | Human Necessities | 4 | Expired |
| US9999596B2 | Controlled release hydrogels | Human Necessities | 1 | Active |
| US8124051B2 | Complex drug delivery composition and method for treating cancer | Human Necessities | 1 | Active |
| US7045134B2 | Borellia burgdorferi epitope peptides | Human Necessities | 0 | Expired |
| US9457099B2 | Polyethylene glycol-based dendrons | Human Necessities | 0 | Active |
| US9421272B2 | Nanocarrier compositions and methods | Human Necessities | 0 | Active |
| US9517201B2 | Nanocarrier and nanogel compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US6913936B2 | Immunological test kit comprising an immunologically invisible peg copolymer conjugated to one or more immunologically reactive substances | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7740882B2 | Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents | Performing Operations; Transporting | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.